Vistogard FDA Approval History
FDA Approved: Yes (First approved December 11, 2015)
Brand name: Vistogard
Generic name: uridine triacetate
Dosage form: Oral Granules
Company: Wellstat Therapeutics Corporation
Treatment for: Fluorouracil Overdose and Capecitabine Overdose
Vistogard (uridine triacetate) is a pyrimidine analog indicated for the emergency treatment of adults and children who receive an overdose of the cancer treatments fluorouracil or capecitabine.
Development Timeline for Vistogard
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.